IMC Chicago
VRTX icon

IMC Chicago’s Vertex Pharmaceuticals VRTX Stock Holding History

IMC Chicago’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.4M Sell
77,100
-21,000
-21% -$9.79M 0.01% 635
2025
Q4 		$44.5M Buy
98,100
+25,600
+35% +$11M 0.02% 528
2025
Q3 		$28.4M Buy
72,500
+59,100
+441% +$24.7M 0.01% 642
2025
Q2 		$5.97M Sell
13,400
-14,000
-51% -$6.45M ﹤0.01% 1280
2025
Q1 		$13.3M Sell
27,400
-43,500
-61% -$20.3M 0.01% 756
2024
Q4 		$28.6M Buy
70,900
+52,500
+285% +$24.3M 0.01% 488
2024
Q3 		$8.56M Buy
18,400
+1,600
+10% +$769K ﹤0.01% 896
2024
Q2 		$7.87M Sell
16,800
-21,700
-56% -$9.42M ﹤0.01% 874
2024
Q1 		$16.1M Sell
38,500
-24,900
-39% -$10.5M 0.01% 536
2023
Q4 		$25.8M Buy
63,400
+22,100
+54% +$8.16M 0.02% 394
2023
Q3 		$14.4M Sell
41,300
-2,500
-6% -$874K 0.01% 456
2023
Q2 		$15.4M Sell
43,800
-3,400
-7% -$1.15M 0.01% 414
2023
Q1 		$14.9M Buy
47,200
+7,100
+18% +$2.13M 0.02% 399
2022
Q4 		$11.6M Buy
40,100
+17,600
+78% +$5.36M 0.02% 433
2022
Q3 		$6.51M Buy
+22,500
New +$6.47M 0.01% 517
2022
Q2 		– Sell
-11,700
Closed -$3.05M – 1185
2022
Q1 		$3.05M Buy
11,700
+1,000
+9% +$237K ﹤0.01% 665
2021
Q4 		$2.35M Sell
10,700
-7,600
-42% -$1.48M ﹤0.01% 777
2021
Q3 		$3.32M Buy
+18,300
New +$3.57M ﹤0.01% 720
2021
Q1 		– Sell
-10,200
Closed -$2.41M – 1194
2020
Q4 		$2.41M Buy
+10,200
New +$2.34M ﹤0.01% 696
2019
Q1 		– Sell
-4,900
Closed -$812K – 908
2018
Q4 		$812K Buy
+4,900
New +$849K ﹤0.01% 492

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

IMC Chicago's VRTX Position: Q1 2026 in Review

IMC Chicago opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 4,533 shares worth $2.02M. The stake represents ﹤0.01% of the portfolio and ranks #2555 among its holdings.

1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • IMC Chicago held 4,533 shares of Vertex Pharmaceuticals worth $2.02M as of Q1 2026.
  • Vertex Pharmaceuticals was a new IMC Chicago position in Q1 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #2555 holding.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.